1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Mission Grants 2025 is sponsored by Home Nursing Agency Foundation. Mission Grants 2025 is a grant from the Home Nursing Agency Foundation that funds programs and services provided by the Home Nursing Agency in patients' homes and in the community throughout 2025.
Get alerted about grants like this
Save a search for “Home Nursing Agency Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Mission Grants 2025 - Home Nursing Agency Foundation Your Gifts at Work — Mission Grants 2025 The Home Nursing Agency Foundation, a community benefit, non-profit organization, recently awarded 20 Mission Grants totaling $187,144 to Agency programs and services. The grants will directly impact patient care and services that are provided in the home and in the community throughout 2025.
The Foundation’s mission is to provide financial support to create, improve, or enhance the Agency’s programs and services that ultimately results in a benefit to the individual, the family, and the community. The Foundation uses donations from individuals, community contributions, and proceeds from fundraising events, like Mercedes Moment, to annually award Mission Grants.
Since 2005, the Foundation has awarded 474 grants totaling $2,952,042. All donations are tax-deductible to the fullest extent of the law and all dollars remain in the community—close to home within the cities, towns, and boroughs served by the Agency. Your support is greatly appreciated!
For more information about how you can make an impact, please visit contact Kim Helsel, Director of Development/Marketing Communications, 814-947-7024 or khelsel@homenursingagency. com .
The following programs and services were awarded Mission Grants for 2025: To help individuals who are facing a life-limiting illness with emergency one-time funding for utility or fuel costs, medications, air conditioners, and other emergencies to ease the emotional and physical challenges occurring at the end of life.
Hospice Educational Resources To purchase educational booklets to be used by the family as a resource for the signs and symptoms of what to expect during the various stages of dying and large-print resources. Education decreases fears of patients and their caregivers, allowing them to have more peace of mind about the future.
To enhance the quality of life for our patients by providing funds for a meal at restaurant to celebrate an anniversary for a dying patient/spouse, for a television for a patient with no other means of entertainment, or for CDs for an anxious patient calmed by music. To recognize hospice patients who are veterans through the presentation of a certificate and special American flag blanket.
Hospice Pill Planners/Education To pay for pill planners and education that ensure medication is dispensed correctly and safely. To provide busy blankets for patients with dementia to keep their hands occupied. To provide bed sheets, pads, hospital gowns, and baby monitors.
Additional items, should they be requested or needed, include cups with straws, sippy cups, neck pillows, and fleece throw blankets. To recognize hospice volunteers through appreciation luncheons and other efforts to demonstrate appreciation for volunteers’ service to hospice patients and families.
To provide individualized patient kits containing blankets, socks, puzzles, activities, voice preservation tools, etc. specific to the patient’s needs. To provide bi-monthly or monthly greeting card outreach to patients who have otherwise declined participation in the volunteer portion of hospice services. To purchase stationery items (cards, grief support literature) for the extended support mailings to bereaved families.
Also to purchase books “Healing After Loss” and journals to be used for those bereaved. To fund a specialized educational event for bereaved individuals in Blair and surrounding counties. To provide emergency funding for life necessities of bereaved family members impacted by the hospice patient’s care or passing.
To supplement overhead costs, including staff time/facility costs, craft/activity supplies, and food. In addition, to cover expenses for staff to facilitate six-week in-school groups with children who would not otherwise have access to a center or grief resources. To provide recognition and additional training opportunities for volunteers who serve as group or sewing volunteers.
To provide funds for local Home Health patients and their families who have need beyond normal circumstances and need assistance to purchase life’s basic necessities, i.e. nutritional supplements, bathing/safety aides, bedding, and emergency medications.
To fund devices to facilitate self/home monitoring of health conditions and increased use of telehealth, including but not limited to blood pressure cuffs, scales, incentive spirometers, and pulse oximeters. To purchase a skills mannequin to be used for interactive and responsive training.
To provide feeding equipment, communication boards, developmental/therapeutic materials educational and safety items, including more costly equipment such as an adapted walker and stander to accommodate clients with multiple disabilities.
WIC (Women, Infants, and Children) To offer diapers or training pants as an incentive for continuing in the WIC program after a child turns 1 or 2 years old, as this is a critical time of growth and development. To cover any critical need for which no formal Grant request had been made or insufficient dollars had been approved. This allocation will be at the discretion of the Grants Committee.
Based on current listing details, eligibility includes: Non-profit organizations providing home and community-based services. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.